Decitabine
- Product NDC
- 68001-422
- 11-digit product format
- 680010422
- Labeler code
- 68001
- Product ID
- 68001-422_a7794bc8-15c1-420b-9018-08f7da3faf8f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Decitabine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- BluePoint Laboratories
- Application
- ANDA206033
- Marketing category
- ANDA
- Marketing start
- 2019-10-21
- Marketing end
- 0000-00-00
- Substance
- DECITABINE
- Active strength
- 50 mg/20mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-422-37 | 68001042237 | 1 VIAL, SINGLE-USE in 1 CARTON (68001-422-37) > 20 mL in 1 VIAL, SINGLE-USE | 2019-10-21 | 0000-00-00 | No | No | Current |